Biocon Biologics completes integration of Viatris Biosimilars’ business in North America
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
These plant locations include Ramagundam, Talcher Kaniha, Korba, Vindhyachal, Dadri, Barh, Solapur, North Karanpura, and Mauda
AAT is a substantial socio-economic burden to livestock farmers in Sub-Saharan Africa, affecting and killing millions of cattle every year
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
Meningitis still affects more than 2.5 million people globally each year
The approval bolsters the company's Mycophenolate Mofetil portfolio
Propranolol LA is a generic equivalent of Inderal LA
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
Subscribe To Our Newsletter & Stay Updated